SCHEMBL8254604

SCHEMBL8254604

CC(C)(C)Nc1ccc(N2CCC2)nc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 1/20 0.46
▸ KDM4E B2RXH2 3/20 0.45
▸ POLB P06746 1/20 0.45
▸ MAPT P10636 7/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ GAA P10253 2/20 0.44
▸ PKM P14618 2/20 0.43
▸ KCNQ3 O43525 1/20 0.42
▸ KCNQ2 O43526 1/20 0.42
▸ LMNA P02545 2/20 0.41
▸ UBE2T Q9NPD8 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ KMT2A Q03164 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8260664 0.95 TRPV1 (0.48) TRPV1KDM4EPOLBMAPTALDH1A1
SCHEMBL13761492 0.87 RAB9A (0.53) KDM4EMAPTALDH1A1GAASMN1; SMN2
SCHEMBL24590133 0.86 MAPT (0.54) KDM4EMAPTALDH1A1GAAKCNQ3
SCHEMBL15179045 0.84 KDM4E (0.50) TRPV1KDM4EMAPTALDH1A1GAA
SCHEMBL26739746 0.81 MAPT (0.45) TRPV1KDM4EMAPTALDH1A1GAA
SCHEMBL8437327 0.80 MAPT (0.44) TRPV1KDM4EMAPTALDH1A1GAA
SCHEMBL4082936 0.77 KCNQ3 (0.48) TRPV1KDM4EMAPTALDH1A1GAA
SCHEMBL24590318 0.77 KMT2A (0.46) KDM4EMAPTALDH1A1GAARAB9A
SCHEMBL21899148 0.77 RET (0.46) TRPV1KDM4EMAPTALDH1A1GAA
SCHEMBL13006763 0.76 MAPT (0.49) TRPV1KDM4EMAPTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275964-A1 CANNABINOID RECEPTOR LIGANDS AND USES THEREOF PFIZER, INC. 2007-11-29 — — US disclosed
US-7268133-B2 Cannabinoid receptor ligands and uses thereof PFIZER, INC. PATENT DEPARTMENT (US) 2007-09-11 — — US disclosed
US-20040214837-A1 Cannabinoid receptor ligands and uses thereof PFIZER INC. 2004-10-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040214837-A1 Cannabinoid receptor ligands and uses thereof CNR1, CNR2, GPR18 TRPV1 16/4885KDM4E 3361/4885POLB 4653/4885
US-20070275964-A1 CANNABINOID RECEPTOR LIGANDS AND USES THEREOF CNR1, CNR2, GPR18 TRPV1 20/4885KDM4E 3352/4885POLB 4664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback